Works matching IS 17762596 AND DT 2024 AND VI 19 AND IP 2

Results: 15

EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 277, doi. 10.1007/s11523-024-01042-3

By:

Zhao, Ruiying;
Li, Jiaqi;
Guo, Lianying;
Xiang, Chan;
Chen, Shengnan;
Zhao, Jikai;
Shao, Jinchen;
Zhu, Lei;
Ye, Min;
Qin, Gang;
Chu, Tianqing;
Han, Yuchen

Publication type:

Article

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Lenvatinib Clinical Trials: A Systematic Review.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 161, doi. 10.1007/s11523-024-01040-5

By:

Crotty, Patrick;
Kari, Karim;
Hughes, Griffin K.;
Ladd, Chase;
McIntire, Ryan;
Gardner, Brooke;
Peña, Andriana M.;
Ferrell, Sydney;
Tuia, Jordan;
Cohn, Jacob;
Haslam, Alyson;
Prasad, Vinay;
Vassar, Matt

Publication type:

Article

Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 213, doi. 10.1007/s11523-024-01044-1

By:

Olkus, Alexander;
Tomczak, Aurelie;
Berger, Anne Katrin;
Rauber, Conrad;
Puchas, Philip;
Wehling, Cyrill;
Longerich, Thomas;
Mehrabi, Arianeb;
Chang, De-Hua;
Liermann, Jakob;
Schäfer, Sophia;
Pfeiffenberger, Jan;
Jäger, Dirk;
Michl, Patrick;
Springfeld, Christoph;
Dill, Michael T.

Publication type:

Article

Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 251, doi. 10.1007/s11523-024-01037-0

By:

Han, Gwan Hee;
Kim, Hae-Rim;
Yun, Hee;
Kim, Jae-Hoon;
Cho, Hanbyoul

Publication type:

Article

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 181, doi. 10.1007/s11523-024-01043-2

By:

Matsumoto, Toshihiko;
Yamamoto, Yoshiyuki;
Kotaka, Masahito;
Masuishi, Toshiki;
Tsuji, Yasushi;
Shoji, Hirokazu;
Hirata, Kenro;
Tsuduki, Takao;
Makiyama, Akitaka;
Izawa, Naoki;
Takahashi, Naoki;
Tsuda, Masahiro;
Yasui, Hisateru;
Ohta, Takashi;
Kito, Yosuke;
Otsu, Satoshi;
Hironaka, Shuichi;
Yamazaki, Kentaro;
Boku, Narikazu;
Hyodo, Ichinosuke

Publication type:

Article

DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 263, doi. 10.1007/s11523-024-01041-4

By:

Ressler, Julia Maria;
Tomasich, Erwin;
Hatziioannou, Teresa;
Ringl, Helmut;
Heller, Gerwin;
Silmbrod, Rita;
Gottmann, Lynn;
Starzer, Angelika Martina;
Zila, Nina;
Tschandl, Philipp;
Hoeller, Christoph;
Preusser, Matthias;
Berghoff, Anna Sophie

Publication type:

Article

Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 237, doi. 10.1007/s11523-024-01039-y

By:

Jin, Dian;
Chen, Haoguang;
He, Jingsong;
Li, Yi;
Zheng, Gaofeng;
Yang, Yang;
Zhao, Yi;
Le, Jing;
Shu, Wenxiu;
He, Donghua;
Cai, Zhen

Publication type:

Article

Modelling the Effectiveness of Tepotinib in Comparison to Standard-of-Care Treatments in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Harbouring METex14 Skipping in the UK.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 191, doi. 10.1007/s11523-024-01038-z

By:

Batteson, Rachael;
Hook, Emma;
Wheat, Hollie;
Hatswell, Anthony J.;
Vioix, Helene;
McLean, Thomas;
Alexopoulos, Stamatia Theodora;
Baijal, Shobhit;
Paik, Paul K.

Publication type:

Article

Sacituzumab Govitecan: A Review in Unresectable or Metastatic HR+/HER2− Breast Cancer.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 289, doi. 10.1007/s11523-024-01036-1

By:

Kang, Connie

Publication type:

Article

Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World Studies.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 203, doi. 10.1007/s11523-024-01035-2

By:

Wang, Bi-Cheng;
Kuang, Bo-Hua;
Lin, Guo-He

Publication type:

Article

Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

Published in:

2024

By:

Tsuboi, Masahiro;
Herbst, Roy S.;
John, Thomas;
Kato, Terufumi;
Majem, Margarita;
Grohé, Christian;
Wang, Jie;
Goldman, Jonathan W.;
Lu, Shun;
de Marinis, Filippo;
Shepherd, Frances A.;
Lee, Ki Hyeong;
Le, Nhieu Thi;
Dechaphunkul, Arunee;
Kowalski, Dariusz;
Bonanno, Laura;
Dómine, Manuel;
Poole, Lynne;
Bolanos, Ana;
Rukazenkov, Yuri

Publication type:

Letter

Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 143, doi. 10.1007/s11523-024-01033-4

By:

Żebrowska, Urszula;
Balwierz, Walentyna;
Wechowski, Jarosław;
Wieczorek, Aleksandra

Publication type:

Article

Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 223, doi. 10.1007/s11523-024-01032-5

By:

Rimini, Margherita;
Loi, Eleonora;
Rizzato, Mario Domenico;
Pressiani, Tiziana;
Vivaldi, Caterina;
Gusmaroli, Eleonora;
Antonuzzo, Lorenzo;
Martinelli, Erika;
Garajova, Ingrid;
Giordano, Guido;
Lucchetti, Jessica;
Schirripa, Marta;
Cornara, Noemi;
Rossari, Federico;
Vitiello, Francesco;
Amadeo, Elisabeth;
Persano, Mara;
Piva, Vittoria Matilde;
Balsano, Rita;
Salani, Francesca

Publication type:

Article

Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy.

Published in:

Targeted Oncology, 2024, v. 19, n. 2, p. 175, doi. 10.1007/s11523-023-01031-y

By:

Buchler, Tomas;
Poprach, Alexandr

Publication type:

Article

Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia—A Podcast.

Published in:

2024

By:

Jabbour, Elias J.;
Stelljes, Matthias

Publication type:

Letter